nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—forebrain—Alzheimer's disease	0.111	0.256	CbGeAlD
Nitroxoline—METAP2—telencephalon—Alzheimer's disease	0.102	0.235	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—TTR—Alzheimer's disease	0.0765	0.135	CbGpPWpGaD
Nitroxoline—METAP2—nervous system—Alzheimer's disease	0.0601	0.139	CbGeAlD
Nitroxoline—METAP2—central nervous system—Alzheimer's disease	0.0579	0.134	CbGeAlD
Nitroxoline—METAP2—cerebellum—Alzheimer's disease	0.0566	0.131	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—LRP1—Alzheimer's disease	0.0474	0.0837	CbGpPWpGaD
Nitroxoline—METAP2—brain—Alzheimer's disease	0.046	0.106	CbGeAlD
Nitroxoline—METAP2—Inactivation, recovery and regulation of the phototransduction cascade—CALM1—Alzheimer's disease	0.0446	0.0787	CbGpPWpGaD
Nitroxoline—METAP2—The phototransduction cascade—CALM1—Alzheimer's disease	0.0435	0.0768	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—LPL—Alzheimer's disease	0.0222	0.0392	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—CALM1—Alzheimer's disease	0.0187	0.033	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOE—Alzheimer's disease	0.0186	0.0329	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ITM2B—Alzheimer's disease	0.014	0.0247	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GAPDHS—Alzheimer's disease	0.0112	0.0198	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TTR—Alzheimer's disease	0.00971	0.0171	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SNCA—Alzheimer's disease	0.00722	0.0127	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TTR—Alzheimer's disease	0.0068	0.012	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PSENEN—Alzheimer's disease	0.00643	0.0114	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APH1A—Alzheimer's disease	0.00635	0.0112	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCSTN—Alzheimer's disease	0.00618	0.0109	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LRP1—Alzheimer's disease	0.00603	0.0106	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PYY—Alzheimer's disease	0.00595	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TPI1—Alzheimer's disease	0.00582	0.0103	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EIF2AK2—Alzheimer's disease	0.00547	0.00966	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GAPDH—Alzheimer's disease	0.00537	0.00948	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDK5—Alzheimer's disease	0.00516	0.0091	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PSEN2—Alzheimer's disease	0.00502	0.00886	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR6—Alzheimer's disease	0.00496	0.00876	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CST3—Alzheimer's disease	0.00491	0.00867	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IAPP—Alzheimer's disease	0.00459	0.00811	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PSENEN—Alzheimer's disease	0.00451	0.00795	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APH1A—Alzheimer's disease	0.00444	0.00784	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCSTN—Alzheimer's disease	0.00433	0.00763	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ENO1—Alzheimer's disease	0.00423	0.00746	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LRP1—Alzheimer's disease	0.00422	0.00745	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPP3CA—Alzheimer's disease	0.00421	0.00742	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GFAP—Alzheimer's disease	0.00412	0.00727	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAL—Alzheimer's disease	0.00412	0.00727	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GAB2—Alzheimer's disease	0.00403	0.00712	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GSK3A—Alzheimer's disease	0.004	0.00706	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APP—Alzheimer's disease	0.00393	0.00694	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—A2M—Alzheimer's disease	0.00363	0.00641	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PSEN2—Alzheimer's disease	0.00352	0.00621	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ADAM10—Alzheimer's disease	0.00338	0.00597	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY—Alzheimer's disease	0.00324	0.00571	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IAPP—Alzheimer's disease	0.00322	0.00568	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CRH—Alzheimer's disease	0.00312	0.00551	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPS—Alzheimer's disease	0.00296	0.00523	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00295	0.0052	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTK2B—Alzheimer's disease	0.0029	0.00512	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAB2—Alzheimer's disease	0.00282	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NTRK2—Alzheimer's disease	0.00282	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SST—Alzheimer's disease	0.00282	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LPL—Alzheimer's disease	0.00282	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GSK3A—Alzheimer's disease	0.0028	0.00494	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APP—Alzheimer's disease	0.00275	0.00486	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKCG—Alzheimer's disease	0.00274	0.00484	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CCR5—Alzheimer's disease	0.0026	0.00459	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLCB1—Alzheimer's disease	0.0026	0.00458	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—Alzheimer's disease	0.00254	0.00448	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NGFR—Alzheimer's disease	0.00242	0.00428	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CALM1—Alzheimer's disease	0.00237	0.00419	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADAM10—Alzheimer's disease	0.00237	0.00418	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOE—Alzheimer's disease	0.00236	0.00417	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CAV1—Alzheimer's disease	0.00234	0.00413	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—S100B—Alzheimer's disease	0.00224	0.00395	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS2—Alzheimer's disease	0.0022	0.00389	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOTCH1—Alzheimer's disease	0.00218	0.00385	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF2—Alzheimer's disease	0.00213	0.00376	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1R—Alzheimer's disease	0.00206	0.00364	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GSK3B—Alzheimer's disease	0.00205	0.00361	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CREB1—Alzheimer's disease	0.00203	0.00358	CbGpPWpGaD
Nitroxoline—METAP2—Disease—INS—Alzheimer's disease	0.00202	0.00357	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LPL—Alzheimer's disease	0.00198	0.00349	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MEF2C—Alzheimer's disease	0.00196	0.00346	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCG—Alzheimer's disease	0.00192	0.00339	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NGF—Alzheimer's disease	0.00187	0.0033	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR5—Alzheimer's disease	0.00182	0.00321	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR2A—Alzheimer's disease	0.00178	0.00314	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS3—Alzheimer's disease	0.00177	0.00313	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CALM1—Alzheimer's disease	0.00166	0.00293	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEP—Alzheimer's disease	0.00166	0.00292	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOE—Alzheimer's disease	0.00166	0.00292	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CAV1—Alzheimer's disease	0.00164	0.0029	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—Alzheimer's disease	0.00162	0.00286	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ESR1—Alzheimer's disease	0.00158	0.00279	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—F2—Alzheimer's disease	0.00156	0.00276	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH1—Alzheimer's disease	0.00153	0.0027	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GSK3B—Alzheimer's disease	0.00143	0.00253	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CREB1—Alzheimer's disease	0.00142	0.00251	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INS—Alzheimer's disease	0.00141	0.0025	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL2—Alzheimer's disease	0.00139	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1—Alzheimer's disease	0.00137	0.00241	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOS3—Alzheimer's disease	0.00124	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFB1—Alzheimer's disease	0.00117	0.00207	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—Alzheimer's disease	0.00105	0.00186	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK8—Alzheimer's disease	0.000968	0.00171	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—Alzheimer's disease	0.000894	0.00158	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—Alzheimer's disease	0.000883	0.00156	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFB1—Alzheimer's disease	0.00082	0.00145	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—Alzheimer's disease	0.000814	0.00144	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—Alzheimer's disease	0.000675	0.00119	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—Alzheimer's disease	0.000618	0.00109	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—Alzheimer's disease	0.00057	0.00101	CbGpPWpGaD
